Publications by authors named "Tim Kutzker"

Claim this Profile
D
Divergent Prognostic Value of Primary Tumor Segmentation Metrics on Baseline FDG PET/CT in Colorectal Cancer.
Ken Kudura, Nando Ritz, Yves Schaulin, Arkadiusz Miszczyszyn, Tim Kutzker

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data.
Ken Kudura, Nando Ritz, Arnoud J Templeton, Tim Kutzker, Martin H K Hoffmann

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition.
Ken Kudura, Nando Ritz, Arnoud J Templeton, Tim Kutzker, Robert Foerster

J Clin Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival.
Ken Kudura, Nando Ritz, Arnoud J Templeton, Marc Kissling, Tim Kutzker

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors.
Ken Kudura, Nando Ritz, Tim Kutzker, Martin H K Hoffmann, Arnoud J Templeton

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. 2021, , 3830.
Ken Kudura, Florentia Dimitriou, Lucas Basler, Robert Förster, Daniela Mihic-Probst, Tim Kutzker

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.
Ken Kudura, Florentia Dimitriou, Lucas Basler, Robert Förster, Daniela Mihic-Probst, Tim Kutzker

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients.
Ken Kudura, Florentia Dimitriou, Daniela Mihic-Probst, Urs J Muehlematter, Tim Kutzker

Diagnostics (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis